Goal 13 of the UN SDG calls for Climate Action. Relative to output, drug manufacturing and supply chains contribute considerably to CO₂ emissions. Small molecule drug production remains an ecologic burden due to their high E factor (ratio of kg waste/kg product). Biopharma manuf. increasingly depends on disposables. Delivery devices are mostly single-use plastics.